AU7625996A - Use of interferon-beta for treating bronchial carcinoma during radiation therapy - Google Patents
Use of interferon-beta for treating bronchial carcinoma during radiation therapyInfo
- Publication number
- AU7625996A AU7625996A AU76259/96A AU7625996A AU7625996A AU 7625996 A AU7625996 A AU 7625996A AU 76259/96 A AU76259/96 A AU 76259/96A AU 7625996 A AU7625996 A AU 7625996A AU 7625996 A AU7625996 A AU 7625996A
- Authority
- AU
- Australia
- Prior art keywords
- interferon
- beta
- radiation therapy
- during radiation
- bronchial carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19544167 | 1995-11-17 | ||
DE1995144167 DE19544167A1 (en) | 1995-11-17 | 1995-11-17 | Use of interferon-ß for the treatment of bronchial carcinoma in radiation therapy |
PCT/EP1996/005044 WO1997018830A1 (en) | 1995-11-17 | 1996-11-18 | USE OF INTERFERON-β FOR TREATING BRONCHIAL CARCINOMA DURING RADIATION THERAPY |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7625996A true AU7625996A (en) | 1997-06-11 |
Family
ID=7778518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU76259/96A Abandoned AU7625996A (en) | 1995-11-17 | 1996-11-18 | Use of interferon-beta for treating bronchial carcinoma during radiation therapy |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7625996A (en) |
DE (1) | DE19544167A1 (en) |
WO (1) | WO1997018830A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI82266C (en) * | 1982-10-19 | 1991-02-11 | Cetus Corp | Process for Preparation of IL-2 Mutein |
CA1291706C (en) * | 1986-04-03 | 1991-11-05 | Alfred Rudolph | COMBINATION THERAPY USING INTERFERON-.beta. AND INTERLEUKIN-2 |
CA1290249C (en) * | 1986-04-09 | 1991-10-08 | Cetus Corporation | COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
DE4128319A1 (en) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | NEW RECOMBINANT HUMAN-IFN-BETA, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
ATE299892T1 (en) * | 1994-05-18 | 2005-08-15 | Nektar Therapeutics | METHODS AND COMPOSITIONS FOR DRY POWDER MEDICATION FROM INTERFERONS |
-
1995
- 1995-11-17 DE DE1995144167 patent/DE19544167A1/en not_active Withdrawn
-
1996
- 1996-11-18 WO PCT/EP1996/005044 patent/WO1997018830A1/en active Application Filing
- 1996-11-18 AU AU76259/96A patent/AU7625996A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997018830A1 (en) | 1997-05-29 |
DE19544167A1 (en) | 1997-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9700939A0 (en) | Compounds and methods for the treatment of cancer | |
AU8397998A (en) | Method and apparatus for radiation and hyperthermia therapy of tumors | |
ZA977087B (en) | Methods of cancer treatment using naaladase inhibitors | |
AU4067697A (en) | Therapeutic compositions for treatment of cancer | |
EP0764030A4 (en) | Use of autoantibodies for tumor therapy and prophylaxis | |
GB9506993D0 (en) | Tumor treatment apparatus | |
AU1980995A (en) | Methods and compositions for treatment of breast cancer | |
AU7012496A (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
AU2701195A (en) | Methods for treating cancer and other cell proliferative diseases | |
AU7380500A (en) | Methods for treating tumors using neutron therapy | |
HUP9900905A3 (en) | Use of vitamin d4 derivatives for treating cancer | |
AU5300396A (en) | Radiation enhanced gene therapy for treatment of tumors | |
IL127605A0 (en) | Methods of cancer treatment using naaladase inhibitors | |
AU2821295A (en) | Compositions and methods for the treatment of tumors | |
EP0959879A4 (en) | Photodynamic therapy for the treatment of osteoarthritis | |
IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
HK1063004A1 (en) | Oxalatoplatin and 5-fluorouracil for combination therapy of cancer | |
AU7223391A (en) | Apparatus for hyperthermia treatment of cancer | |
IL115320A0 (en) | Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases | |
AU3118697A (en) | Radiation therapy dose calculation engine | |
AU1979499A (en) | Apparatus for therapeutic electromagnetic treatment | |
AU7770991A (en) | Method and composition for the treatment of cancer | |
AU3973793A (en) | Method of treating cancer | |
AU5369498A (en) | Compounds and methods for treating cancer | |
AU7625996A (en) | Use of interferon-beta for treating bronchial carcinoma during radiation therapy |